Skip to Content
Find More Like This
Return to Search

EGVI Endoglucanase and Nucleic Acids Encoding the Same

United States Patent Application

View the Complete Application at the US Patent & Trademark Office
National Renewable Energy Laboratory - Visit the NREL Technology Transfer Website
The present invention provides a novel endoglucanase nucleic acid sequence, designated egl6, and the corresponding EGVI amino acid sequence. The invention also provides expression vectors and host cells comprising a nucleic acid sequence encoding EGVI, recombinant EGVI proteins and methods for producing the same.
DUNN-COLEMAN, Nigel (El Sauzal, ES), GOEDEGEBUUR, Frits (Vlaardingen, NL), WARD, Michael (San Francisco, CA), YAO, Jian (Sunnyvale, CA)
14/ 167,779
January 29, 2014
GOVERNMENT SUPPORT [0002] Portions of this work were funded by Subcontract No. ZCO-30017-01 with the National Renewable Energy Laboratory under Prime Contract No. DE-AC36-99GO10337 with the U.S. Department of Energy. Accordingly, the United States Government may have certain rights in this invention.